Dose adjustments of antimicrobials in patients with hepatic impairment An overview of appropriate dosing of antimicrobials in patients with hepatic impairment.…
Liver function tests: indication and interpretation This article describes the liver function tests, aiming to support pharmacists in using them and in interpreting their results.…
Medicines management in adult patients undergoing liver transplantation Medication regimes for patients undergoing liver transplantation can be complex, meaning pharmacists must consider how best to optimise medicines and manage side effects.…
Primary biliary cholangitis: diagnosis and management Primarily affecting women, primary biliary cholangitis is a progressive condition that can result in end-stage liver disease.…
A day in the life of a liver intensive therapy unit pharmacist Sara Sawieres details a typical day as lead pharmacist for the liver intensive therapy unit at King’s College Hospital.…
Palliative management in end-stage liver disease Early palliative interventions, including reviewing regular medicines and managing common symptoms, enables patients to remain comfortable during end-of-life care.…
Proton pump inhibitors linked to liver disease, researchers find Researchers have found evidence that use of proton pump inhibitors (PPIs) may cause changes to gut bacteria that can promote liver disease.…
Direct-acting antivirals successfully treating hepatitis C, says Public Health England Public Health England is urging the public to get tested for hepatitis C after its latest figures revealed a fall in deaths from the disease, which it attributed to the introduction of direct-acting antiviral therapy.…
European conditional approval given for rare liver disease drug The European Medicine Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended a new drug to treat a rare and potentially lethal liver disease for conditional marketing approval across the EU. Obeticholic acid (Ocaliva; Intercept Pharma) has been re…
Obeticholic acid gets US approval for rare liver disease The US Food and Drug Administration has approved a new drug called Ocaliva (obeticholic acid) for patients with primary biliary cholangitis. …
